The Journal of Infectious Diseases · 2007 · 37 citations · 45 references
Life SciencesImmunologyInfectious DiseasesClinical ImmunologyImmunology Of Infectious DiseasesPediatric ImmunologyAntigen PresentationAntigen RecognitionCytotoxic T Lymphocyte ResponsesNeonatal ImmunologyPediatric Clinical ImmunologyT Cell ActivationCd8 Positive T Cell ResponsesCytomegalovirus DiseaseNeonatal Immune Response To InfectionPeptide Antigen RecognitionPeptide EpitopesPeptide SpecificityPrimary InfectionSignal Peptide Recognition
Cytomegalovirus (CMV) infection remains a significant cause of morbidity and mortality in young children. We have previously shown that CD8+ T cell responses to CMV pp65 or IE1 protein were readily detectable in children with congenital or postnatal CMV infection. Here, we have further characterized the evolution of the peptide specificity of these responses in 7 infants<6 months of age at the start of the study. Thirteen pp65 and 15 IE1 peptides (median, 5 peptides/infant) were targeted, and most (61%) represented sequences not previously reported. Peptide specificity remained stable or broadened over time despite the clearance of CMV viremia. Loss of peptide recognition was not observed. Responses with the highest functional peptide avidity were not necessarily detected earliest. These data provide additional evidence that young infants can generate diverse CMV-specific CD8+ T cell responses but show that early responses may exhibit relatively focused peptide specificity and lower peptide avidity.
45
Andrew Sylwester, Bridget L. Mitchell, John B. Edgar et al. · The Journal of Experimental Medicine · 2005 · 1.3K citations · Full text
Mark R. Wills, A.J. Carmichael, Kim Mynard et al. · Journal of Virology · 1996 · 690 citations · Full text